P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy

Although electroconvulsive therapy (ECT) is among the most effective treatment options for pharmacoresistant major depressive disorder (MDD), some patients still remain refractory to standard ECT practise. Thus, there is a need for markers reliably predicting ECT non/response. In our study, we have...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transl Psychiatry
Asıl Yazarlar: Neyazi, Alexandra, Theilmann, Wiebke, Brandt, Claudia, Rantamäki, Tomi, Matsui, Nobuaki, Rhein, Mathias, Kornhuber, Johannes, Bajbouj, Malek, Sperling, Wolfgang, Bleich, Stefan, Frieling, Helge, Löscher, Wolfgang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5802592/
https://ncbi.nlm.nih.gov/pubmed/29353887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-017-0077-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller